Clinical Trial Update: Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating patient-derived autologous stem cell therapy for diabetic kidney disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Kidney Disease
• Diabetic Nephropathy

Drugs mentioned

• Autologous patient-derived stem cell therapy

Snippet

Sponsor: Mayo Clinic | Conditions: Diabetic Kidney Disease, Diabetic Nephropathies | Phase 1 | Status: TERMINATED